KPRX compared with OTLK: revenue, margins and what each company keeps, and the suppliers and customers both name

KPRXKiora Pharmaceuticals Inc

Mkt capRevenueRevenue

OTLKOutlook Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

KPRXKiora Pharmaceuticals Inc

OTLKOutlook Therapeutics, Inc.

Price

Mkt cap

Revenue

Earnings history

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

last 4 reports each · paired by recencyMethod ›

KPRX1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▲+3.13%—

OTLK1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±23.6%▼−14.90%×0.63

= impliedKPRX realized, solidOTLK realized, hatchedOne scale, both sides: full bar = 24%× = |realized| ÷ impliedSource: market data

KPRXKiora Pharmaceuticals Inc

1.62▲+3.86%· post 1.62

Mkt cap$6.9MRevenue$20,000Q2 FY24

OTLKOutlook Therapeutics, Inc.

0.46▼−1.20%· post 0.47

ClosedNov 2 '26

Mkt cap$114.0MRevenue$8,700Q3 FY26

Compare

ClosedNov 2 '26

KPRXKiora Pharmaceuticals Inc

OTLKOutlook Therapeutics, Inc.

1.62▲+3.86%post 1.62

Price

0.46▼−1.20%post 0.47

$6.9M

Mkt cap

$114.0M

Q2 FY24$20,000

Revenue

$8,700Q3 FY26

KPRX1.62▲+3.86%vsOTLK0.46▼−1.20%ClosedNov 2 '26